Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Stephen Waldo

Concepts (419)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
77
2025
549
17.810
Why?
Coronary Artery Disease
45
2025
747
10.290
Why?
United States Department of Veterans Affairs
33
2025
773
5.520
Why?
Coronary Angiography
31
2025
328
3.510
Why?
Peripheral Arterial Disease
25
2020
506
3.160
Why?
Myocardial Infarction
29
2025
1210
3.130
Why?
Endovascular Procedures
18
2020
389
2.920
Why?
Femoral Artery
13
2022
190
2.640
Why?
Acute Coronary Syndrome
8
2025
297
2.610
Why?
Treatment Outcome
91
2025
11741
2.540
Why?
Veterans
18
2025
1625
2.520
Why?
Vascular Calcification
9
2022
110
2.310
Why?
Veterans Health
7
2025
189
2.220
Why?
Stents
21
2019
561
2.150
Why?
ST Elevation Myocardial Infarction
6
2022
64
2.070
Why?
Popliteal Artery
11
2020
62
2.060
Why?
Atherectomy
11
2022
37
1.890
Why?
Myocardial Ischemia
6
2025
285
1.890
Why?
Risk Factors
70
2025
10857
1.860
Why?
Coronary Artery Bypass
8
2025
268
1.850
Why?
Registries
28
2023
2401
1.810
Why?
United States
64
2026
16065
1.730
Why?
Ischemia
11
2020
422
1.710
Why?
Time Factors
52
2025
7107
1.660
Why?
Atherectomy, Coronary
5
2022
10
1.650
Why?
Aged
89
2026
26096
1.600
Why?
Risk Assessment
29
2025
3740
1.590
Why?
Platelet Aggregation Inhibitors
8
2025
499
1.530
Why?
Radial Artery
7
2022
75
1.500
Why?
Lower Extremity
4
2018
440
1.500
Why?
Angioplasty, Balloon, Coronary
6
2017
156
1.480
Why?
Time-to-Treatment
5
2024
250
1.450
Why?
Hospitals, Veterans
5
2025
258
1.350
Why?
Middle Aged
82
2025
36126
1.330
Why?
Humans
160
2026
145140
1.290
Why?
Cardiovascular Agents
7
2023
166
1.290
Why?
Non-ST Elevated Myocardial Infarction
3
2020
26
1.240
Why?
Hospital Mortality
13
2025
1038
1.200
Why?
Biological Products
2
2023
257
1.200
Why?
Male
103
2026
72664
1.170
Why?
Coronary Restenosis
4
2017
22
1.150
Why?
Coronary Vessels
7
2025
246
1.150
Why?
Angioplasty, Balloon
9
2020
94
1.130
Why?
Female
97
2026
78636
1.050
Why?
Myocardial Revascularization
3
2019
85
1.040
Why?
Access to Information
2
2019
47
1.020
Why?
Retrospective Studies
54
2026
17247
1.010
Why?
Catheterization, Peripheral
2
2019
120
0.990
Why?
Stroke Volume
4
2026
653
0.940
Why?
Surgical Procedures, Operative
3
2025
271
0.910
Why?
Exercise Test
3
2025
626
0.900
Why?
Angina, Stable
3
2022
18
0.890
Why?
Patient Readmission
9
2025
769
0.880
Why?
Eligibility Determination
1
2025
72
0.850
Why?
Coated Materials, Biocompatible
6
2020
65
0.840
Why?
Natural Language Processing
1
2025
106
0.830
Why?
Quality Improvement
5
2025
1293
0.820
Why?
Quality of Health Care
3
2025
692
0.810
Why?
Delivery of Health Care, Integrated
2
2025
299
0.810
Why?
Cardiology
4
2022
360
0.800
Why?
Myocardial Reperfusion
2
2013
56
0.790
Why?
Community Health Services
1
2025
231
0.780
Why?
Cardiac Catheterization
5
2025
558
0.770
Why?
Vascular Patency
14
2020
121
0.750
Why?
Ventricular Function, Left
3
2021
539
0.750
Why?
Chickens
1
2023
179
0.740
Why?
Coronary Thrombosis
4
2015
25
0.710
Why?
Heart Arrest
3
2017
408
0.710
Why?
Vascular Access Devices
5
2020
30
0.710
Why?
Elective Surgical Procedures
2
2020
202
0.700
Why?
Psoriasis
1
2023
115
0.700
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2023
442
0.700
Why?
Healthcare Disparities
3
2024
731
0.690
Why?
California
18
2019
471
0.690
Why?
Practice Patterns, Physicians'
7
2025
1365
0.670
Why?
Anemia
2
2022
190
0.660
Why?
Coronary Occlusion
2
2023
20
0.660
Why?
Aged, 80 and over
23
2025
8318
0.660
Why?
Heart Failure, Systolic
1
2021
26
0.660
Why?
Patient Selection
1
2025
733
0.650
Why?
Drug-Eluting Stents
6
2017
88
0.620
Why?
Hospitals, Community
1
2020
67
0.620
Why?
Assisted Circulation
1
2019
26
0.610
Why?
Paclitaxel
2
2019
256
0.600
Why?
Hemorrhage
5
2022
822
0.600
Why?
Electronic Health Records
3
2025
1188
0.600
Why?
Hemostatic Techniques
1
2020
52
0.600
Why?
Cardiovascular Diseases
4
2025
2183
0.590
Why?
Embolic Protection Devices
1
2019
12
0.580
Why?
Quality Indicators, Health Care
4
2025
336
0.580
Why?
Saphenous Vein
1
2019
37
0.580
Why?
Intra-Aortic Balloon Pumping
1
2019
19
0.580
Why?
Graft Occlusion, Vascular
1
2019
40
0.570
Why?
Heart Failure
7
2026
2324
0.570
Why?
Postoperative Hemorrhage
1
2020
105
0.570
Why?
Databases, Factual
11
2025
1488
0.560
Why?
Cardiac Surgical Procedures
2
2022
608
0.550
Why?
Postoperative Complications
5
2025
2961
0.550
Why?
Fibrinolytic Agents
2
2018
297
0.550
Why?
Electrocardiography
4
2015
664
0.550
Why?
Arterial Occlusive Diseases
1
2018
90
0.530
Why?
Arm
1
2018
110
0.530
Why?
Peripheral Vascular Diseases
1
2018
104
0.530
Why?
Odds Ratio
8
2021
1082
0.530
Why?
Thromboembolism
1
2018
129
0.510
Why?
Cerebrovascular Disorders
1
2018
104
0.510
Why?
Kaplan-Meier Estimate
12
2020
968
0.510
Why?
Limb Salvage
7
2019
73
0.500
Why?
Propensity Score
6
2024
374
0.500
Why?
Renal Artery Obstruction
1
2017
30
0.500
Why?
Embolism
1
2017
48
0.490
Why?
Renal Artery
1
2017
43
0.490
Why?
Research Report
1
2017
86
0.490
Why?
Aspirin
2
2019
406
0.490
Why?
Contrast Media
4
2025
497
0.480
Why?
Hospitals
4
2023
732
0.480
Why?
Transcatheter Aortic Valve Replacement
3
2025
153
0.470
Why?
Catheterization
3
2021
183
0.460
Why?
Coronary Stenosis
5
2020
40
0.450
Why?
Iliac Artery
4
2019
55
0.440
Why?
Hypertension, Pulmonary
5
2025
1955
0.420
Why?
Disclosure
1
2015
84
0.420
Why?
Hospitalization
4
2025
2458
0.420
Why?
Risk Reduction Behavior
1
2016
217
0.420
Why?
Cell Separation
1
2015
304
0.400
Why?
Atherosclerosis
3
2019
409
0.400
Why?
Survival Rate
7
2026
2087
0.400
Why?
Depressive Disorder
1
2017
372
0.400
Why?
Thrombectomy
2
2014
78
0.400
Why?
Cohort Studies
10
2023
5988
0.390
Why?
Cardiologists
2
2025
45
0.380
Why?
Vascular Surgical Procedures
1
2016
343
0.370
Why?
Disease Management
1
2017
651
0.370
Why?
Predictive Value of Tests
9
2025
2115
0.370
Why?
Acute Kidney Injury
5
2025
872
0.370
Why?
Peer Review
2
2025
47
0.360
Why?
Incidence
8
2025
2915
0.360
Why?
HIV
1
2013
251
0.350
Why?
Logistic Models
6
2017
2133
0.350
Why?
Intermittent Claudication
3
2017
122
0.340
Why?
Attitude of Health Personnel
1
2019
1186
0.340
Why?
Hypothermia
1
2011
53
0.330
Why?
Hemodynamics
5
2026
1115
0.330
Why?
Out-of-Hospital Cardiac Arrest
2
2024
121
0.320
Why?
Cause of Death
3
2023
470
0.320
Why?
Stroke
7
2025
1270
0.310
Why?
Severity of Illness Index
8
2025
2928
0.310
Why?
Aortic Valve Stenosis
2
2025
255
0.300
Why?
Constriction, Pathologic
9
2020
248
0.290
Why?
Mentoring
2
2023
165
0.290
Why?
Proportional Hazards Models
9
2023
1325
0.290
Why?
Peptide Fragments
2
2015
693
0.290
Why?
Chi-Square Distribution
4
2018
527
0.290
Why?
Mortality
3
2020
378
0.280
Why?
Endothelial Cells
1
2015
873
0.280
Why?
Punctures
2
2019
41
0.280
Why?
Angiography
6
2020
208
0.270
Why?
Laser Therapy
2
2019
142
0.260
Why?
Natriuretic Peptide, Brain
1
2008
109
0.260
Why?
Carotid Stenosis
2
2018
106
0.250
Why?
Myocardial Perfusion Imaging
2
2019
50
0.250
Why?
Cardiac Output, High
1
2026
1
0.240
Why?
Recurrence
9
2019
1134
0.240
Why?
Sex Factors
5
2025
2099
0.240
Why?
Emergency Medical Services
1
2013
684
0.240
Why?
Follow-Up Studies
7
2026
5411
0.240
Why?
Multivariate Analysis
5
2017
1546
0.230
Why?
Ventricular Dysfunction, Left
2
2021
393
0.230
Why?
Macrophages
3
2008
1500
0.230
Why?
Acute Disease
3
2017
1035
0.220
Why?
Purinergic P2Y Receptor Antagonists
2
2023
71
0.220
Why?
HIV Infections
3
2023
3186
0.220
Why?
Cytochrome P-450 CYP2C19
1
2025
26
0.220
Why?
Ultrasonography, Interventional
2
2025
165
0.220
Why?
Peer Review, Health Care
1
2025
4
0.220
Why?
Patient Discharge
3
2022
991
0.220
Why?
Renal Insufficiency, Chronic
2
2023
661
0.220
Why?
Chest Pain
3
2022
99
0.210
Why?
Chemokine CXCL12
1
2025
86
0.210
Why?
Tomography, Optical Coherence
2
2025
271
0.210
Why?
Travel
1
2025
136
0.210
Why?
Comorbidity
5
2020
1657
0.210
Why?
Pancreas
2
2004
341
0.210
Why?
Prosthesis Failure
2
2016
125
0.200
Why?
Health Services Accessibility
2
2025
1099
0.200
Why?
Hypertension, Portal
1
2024
66
0.200
Why?
Hypothermia, Induced
1
2024
95
0.190
Why?
Coronary Circulation
2
2014
134
0.190
Why?
Fractional Flow Reserve, Myocardial
2
2020
10
0.190
Why?
Biological Therapy
1
2023
28
0.190
Why?
Heart Valve Prosthesis Implantation
1
2025
198
0.190
Why?
Cross-Sectional Studies
6
2022
5886
0.190
Why?
New York
3
2017
128
0.180
Why?
Work Engagement
1
2022
14
0.180
Why?
Prognosis
6
2021
4310
0.180
Why?
Chronic Disease
5
2023
1806
0.180
Why?
Leukocytes
1
2003
296
0.170
Why?
Technology Transfer
1
2021
9
0.170
Why?
Clinical Decision-Making
1
2025
362
0.170
Why?
Social Class
1
2023
264
0.170
Why?
Critical Illness
8
2020
899
0.170
Why?
Shock, Cardiogenic
2
2021
65
0.160
Why?
Angina Pectoris
1
2020
75
0.160
Why?
Aftercare
1
2022
222
0.160
Why?
Mandatory Reporting
2
2017
45
0.160
Why?
Thrombocytopenia
1
2022
204
0.150
Why?
Anticoagulants
2
2016
748
0.150
Why?
Massachusetts
2
2017
180
0.150
Why?
Genome-Wide Association Study
2
2025
1376
0.150
Why?
Delivery of Health Care
2
2023
946
0.150
Why?
Patient Care Team
1
2025
696
0.150
Why?
Echocardiography, Stress
1
2019
29
0.150
Why?
Vascular Resistance
1
2020
369
0.140
Why?
Health Facilities
1
2019
85
0.140
Why?
Referral and Consultation
1
2025
862
0.140
Why?
Intraoperative Period
1
2019
69
0.140
Why?
Ambulatory Surgical Procedures
1
2019
79
0.140
Why?
Heart
1
2022
626
0.140
Why?
Fluid Therapy
1
2020
154
0.140
Why?
Socioeconomic Factors
1
2023
1321
0.140
Why?
Centralized Hospital Services
1
2018
6
0.140
Why?
Thrombosis
1
2022
401
0.140
Why?
Colorado
8
2019
4538
0.140
Why?
Angioplasty, Balloon, Laser-Assisted
1
2017
1
0.140
Why?
Secondary Prevention
1
2019
251
0.140
Why?
Biomarkers
4
2017
4282
0.130
Why?
Angioplasty
1
2018
50
0.130
Why?
Pregnancy-Associated Plasma Protein-A
1
2017
14
0.130
Why?
Perception
1
2021
377
0.130
Why?
Disease-Free Survival
5
2017
766
0.130
Why?
Cardiac Catheters
1
2017
16
0.130
Why?
Transportation of Patients
1
2018
65
0.130
Why?
Diabetes Mellitus, Type 2
2
2023
2578
0.130
Why?
Rosuvastatin Calcium
1
2017
21
0.130
Why?
Perioperative Care
1
2020
231
0.130
Why?
Macrophage Colony-Stimulating Factor
2
2008
20
0.130
Why?
ADAMTS13 Protein
1
2017
7
0.130
Why?
Pulmonary Artery
1
2023
1126
0.130
Why?
Algorithms
2
2017
1845
0.130
Why?
Computer Simulation
1
2021
1002
0.130
Why?
Neck
1
2017
108
0.130
Why?
Thrombotic Microangiopathies
1
2017
19
0.130
Why?
Ankle Brachial Index
1
2017
41
0.130
Why?
Risk
2
2019
916
0.120
Why?
Suction
2
2014
32
0.120
Why?
Policy Making
1
2017
83
0.120
Why?
Reproducibility of Results
5
2025
3410
0.120
Why?
Clinical Competence
1
2025
1240
0.120
Why?
Flow Cytometry
2
2015
1159
0.120
Why?
Aortic Valve
1
2019
364
0.120
Why?
Health Services Needs and Demand
1
2018
279
0.120
Why?
Boston
1
2016
93
0.120
Why?
Academic Medical Centers
2
2016
552
0.110
Why?
Adult
7
2024
40665
0.110
Why?
Dyslipidemias
1
2017
184
0.110
Why?
Pandemics
2
2021
1703
0.110
Why?
Receptors, Cytoplasmic and Nuclear
2
2007
207
0.110
Why?
Burnout, Professional
1
2022
486
0.110
Why?
Cholesterol
2
2008
406
0.110
Why?
Gene Expression Profiling
2
2015
1763
0.110
Why?
Contraindications
1
2014
90
0.110
Why?
Aortic Diseases
1
2016
125
0.110
Why?
Antithrombins
1
2015
71
0.110
Why?
Models, Cardiovascular
1
2015
195
0.100
Why?
Collateral Circulation
1
2014
20
0.100
Why?
Prevalence
2
2019
2855
0.100
Why?
Heparin
1
2015
246
0.100
Why?
Observer Variation
3
2025
356
0.100
Why?
Prospective Studies
3
2020
8035
0.100
Why?
Incidental Findings
1
2013
81
0.100
Why?
Diabetes Mellitus
2
2018
1092
0.090
Why?
Primary Prevention
1
2014
218
0.090
Why?
Resuscitation
1
2015
310
0.090
Why?
Smoking Cessation
1
2016
437
0.090
Why?
Coronary Disease
1
2014
381
0.090
Why?
Trazodone
1
2011
2
0.090
Why?
Antimanic Agents
1
2011
19
0.090
Why?
Glucagon-Like Peptide-1 Receptor
2
2023
88
0.090
Why?
Lithium
1
2011
40
0.090
Why?
Triazines
1
2011
49
0.080
Why?
Laboratories
2
2022
110
0.080
Why?
American Heart Association
2
2022
357
0.080
Why?
Prosthesis Design
3
2017
354
0.080
Why?
Benzodiazepines
1
2011
168
0.080
Why?
Decision Support Techniques
1
2014
472
0.080
Why?
Age Factors
4
2019
3338
0.070
Why?
Cell Differentiation
2
2008
2040
0.070
Why?
Lipoproteins, LDL
2
2007
119
0.070
Why?
Anticonvulsants
1
2011
246
0.070
Why?
Bipolar Disorder
1
2011
275
0.070
Why?
MicroRNAs
1
2015
686
0.070
Why?
Depression
1
2018
1537
0.070
Why?
Pinocytosis
1
2007
6
0.070
Why?
Ultrasonography, Doppler, Duplex
2
2017
40
0.060
Why?
Monocytes
2
2007
537
0.060
Why?
Area Under Curve
1
2008
329
0.060
Why?
Animals
4
2025
37952
0.060
Why?
Seizures
1
2011
482
0.060
Why?
Fluorescent Antibody Technique
1
2008
365
0.060
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
161
0.060
Why?
Adrenergic beta-Antagonists
2
2019
252
0.060
Why?
Drug Overdose
1
2011
374
0.060
Why?
Phenotype
2
2021
3138
0.060
Why?
Polymorphism, Single Nucleotide
2
2025
2136
0.060
Why?
ROC Curve
1
2008
617
0.060
Why?
Inflammation
3
2008
2876
0.060
Why?
Equipment Design
2
2018
525
0.060
Why?
Shock
2
2004
109
0.060
Why?
Polymerase Chain Reaction
1
2008
1039
0.050
Why?
Program Evaluation
2
2019
943
0.050
Why?
Ventricular Fibrillation
1
2024
64
0.050
Why?
Health Plan Implementation
1
2025
141
0.050
Why?
Survival Analysis
2
2020
1371
0.050
Why?
Lipid Metabolism
1
2008
529
0.050
Why?
Trypsin
1
2004
75
0.050
Why?
Exercise
1
2016
2191
0.050
Why?
Amylases
1
2003
18
0.050
Why?
Matrix Metalloproteinase 9
1
2004
130
0.050
Why?
Chymotrypsin
1
2003
23
0.050
Why?
Ezetimibe
1
2023
24
0.050
Why?
Length of Stay
2
2019
1348
0.050
Why?
Tissue Distribution
1
2003
335
0.050
Why?
Tachycardia, Ventricular
1
2024
180
0.050
Why?
Drug Therapy, Combination
2
2016
1043
0.050
Why?
Hypoglycemic Agents
2
2023
1393
0.050
Why?
Polymorphism, Genetic
1
2025
614
0.050
Why?
Glucagon-Like Peptide 1
1
2023
148
0.050
Why?
Pancreatitis
1
2003
146
0.040
Why?
Rats, Wistar
1
2003
449
0.040
Why?
Liver Cirrhosis
1
2024
287
0.040
Why?
Personnel Turnover
1
2022
40
0.040
Why?
Practice Guidelines as Topic
2
2020
1579
0.040
Why?
Cell Death
1
2003
382
0.040
Why?
Cholesterol, LDL
1
2023
360
0.040
Why?
Reperfusion Injury
1
2004
292
0.040
Why?
Troponin
1
2021
50
0.040
Why?
Neutrophils
2
2004
1123
0.040
Why?
Consensus
1
2023
478
0.040
Why?
Organizational Culture
1
2022
161
0.040
Why?
Disease Progression
2
2019
2857
0.040
Why?
Systole
1
2021
181
0.040
Why?
Inpatients
1
2025
552
0.040
Why?
Cells, Cultured
1
2008
4142
0.040
Why?
Ambulatory Care
1
2025
608
0.040
Why?
Genotype
1
2025
1844
0.040
Why?
Free Radical Scavengers
1
2020
82
0.040
Why?
Cytokines
1
2008
2048
0.040
Why?
DNA-Binding Proteins
1
2007
1479
0.040
Why?
Sodium Bicarbonate
1
2020
47
0.040
Why?
Job Satisfaction
1
2022
236
0.040
Why?
Sodium
1
2020
198
0.040
Why?
Acetylcysteine
1
2020
139
0.040
Why?
Hospitals, High-Volume
1
2019
50
0.040
Why?
Exercise Tolerance
1
2021
283
0.040
Why?
Cost Savings
1
2019
86
0.040
Why?
Endocrinologists
1
2018
12
0.040
Why?
Angiotensin Receptor Antagonists
1
2019
115
0.040
Why?
Drug Utilization
1
2019
167
0.040
Why?
Retreatment
1
2018
79
0.040
Why?
Hypertension
2
2018
1269
0.040
Why?
Comparative Effectiveness Research
1
2019
167
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2019
229
0.030
Why?
Rats
2
2004
5582
0.030
Why?
Singapore
1
2017
27
0.030
Why?
Republic of Korea
1
2017
43
0.030
Why?
Transcription Factors
1
2006
1731
0.030
Why?
Angina, Unstable
1
2017
83
0.030
Why?
Purpura, Thrombotic Thrombocytopenic
1
2017
14
0.030
Why?
Combined Modality Therapy
1
2020
1264
0.030
Why?
New Jersey
1
2016
16
0.030
Why?
Michigan
1
2016
134
0.030
Why?
Glomerular Filtration Rate
1
2020
765
0.030
Why?
Aortography
1
2016
52
0.030
Why?
Platelet Aggregation
1
2016
99
0.030
Why?
Postoperative Care
1
2017
286
0.030
Why?
Glucose
1
2020
1048
0.030
Why?
Linear Models
1
2017
844
0.030
Why?
Guideline Adherence
1
2019
586
0.030
Why?
Drug Prescriptions
1
2017
287
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1742
0.030
Why?
Hirudins
1
2015
53
0.030
Why?
Blood Transfusion
1
2017
407
0.030
Why?
Protective Factors
1
2014
99
0.030
Why?
Blood Coagulation
1
2016
274
0.030
Why?
Genetic Predisposition to Disease
1
2022
2351
0.020
Why?
Clinical Trials as Topic
1
2019
1058
0.020
Why?
Health Policy
1
2016
400
0.020
Why?
Blood Flow Velocity
1
2014
420
0.020
Why?
Emergencies
1
2013
174
0.020
Why?
Lipids
1
2017
706
0.020
Why?
Recombinant Proteins
1
2015
1368
0.020
Why?
Cost-Benefit Analysis
1
2014
640
0.020
Why?
Health Care Costs
1
2014
425
0.020
Why?
Kidney Failure, Chronic
1
2017
599
0.020
Why?
Longitudinal Studies
1
2018
2949
0.020
Why?
Models, Biological
1
2017
1763
0.020
Why?
Surveys and Questionnaires
1
2022
6055
0.020
Why?
Medicare
1
2014
902
0.020
Why?
Clofibrate
1
2007
3
0.020
Why?
Orphan Nuclear Receptors
1
2007
14
0.020
Why?
Hydrocarbons, Fluorinated
1
2007
8
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2007
17
0.020
Why?
Liver X Receptors
1
2007
29
0.020
Why?
beta-Cyclodextrins
1
2007
32
0.020
Why?
Mice
1
2025
18303
0.020
Why?
Fluorocarbons
1
2007
119
0.010
Why?
Down-Regulation
1
2007
618
0.010
Why?
Physicians
1
2013
954
0.010
Why?
Mesenteric Arteries
1
2004
17
0.010
Why?
Jejunum
1
2004
37
0.010
Why?
Interleukin-10
1
2006
309
0.010
Why?
Telemedicine
1
2013
956
0.010
Why?
Gelatin
1
2004
56
0.010
Why?
Peroxidase
1
2004
168
0.010
Why?
Sulfonamides
1
2007
583
0.010
Why?
Microscopy, Fluorescence
1
2004
408
0.010
Why?
Enzyme Activation
1
2004
762
0.010
Why?
Blotting, Western
1
2004
1177
0.010
Why?
Rats, Sprague-Dawley
1
2004
2524
0.010
Why?
Waldo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)